OSCR

$13.51

Post-MarketAs of Mar 17, 8:00 PM UTC

Oscar Health, Inc.

Recent News

Simply Wall St.
Mar 15, 2026

Assessing Oscar Health (OSCR) Valuation After Recent Share Price Volatility

Oscar Health stock performance snapshot Oscar Health (OSCR) has drawn investor attention after recent trading left the shares at a last close of $13.23, with returns mixed across different time frames and financial results showing both growth and ongoing losses. See our latest analysis for Oscar Health. Recent trading has been choppy, with a 1 day share price return of 1.77% and a 90 day share price return decline of 18.03%, while the 3 year total shareholder return of about 3x suggests that...

BULLISH
Positive press. Headlines skewed toward growth and analyst upgrades.
Zacks
Mar 13, 2026

Oscar Health, Inc. (OSCR) Rises As Market Takes a Dip: Key Facts

Oscar Health, Inc. (OSCR) closed at $13.23 in the latest trading session, marking a +1.77% move from the prior day.

NEUTRAL
Neutral flow. Standard news cycle with no clear sentiment tilt.
StockStory
Mar 13, 2026

1 Unprofitable Stock to Own for Decades and 2 Facing Challenges

Running at a loss can be a red flag. Many of these businesses face mounting challenges as competition increases and funding becomes harder to secure.

BULLISH
Positive press. Headlines skewed toward growth and analyst upgrades.
Zacks
Mar 12, 2026

Oscar Health, Inc. (OSCR) Falls More Steeply Than Broader Market: What Investors Need to Know

The latest trading day saw Oscar Health, Inc. (OSCR) settling at $13, representing a -2.99% change from its previous close.

NEUTRAL
Neutral flow. Standard news cycle with no clear sentiment tilt.
Insider Monkey
Mar 11, 2026

Raymond James Upgrades Oscar Health, Inc. (OSCR), UBS Lowers PT

Oscar Health, Inc. (NYSE:OSCR) is one of the best under-the-radar stocks to buy according to hedge funds. On February 12, Raymond James upgraded its rating on Oscar Health, Inc. (NYSE:OSCR) from Market Perform to Outperform with a price target of $18 on the stock. Raymond James said the stock’s valuation now looks appealing as margins […]

BULLISH
Positive press. Headlines skewed toward growth and analyst upgrades.
OSCR (Oscar Health, Inc) Stock Analysis | Whystock